Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
-16.13%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$6.47B
AUM Growth
-$1.2B
(-16%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
22.76%
Holding
1,027
New
11
Increased
630
Reduced
329
Closed
21
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$17M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$13.6M |
| 3 |
UnitedHealth
UNH
|
$13.3M |
| 4 |
S&P Global
SPGI
|
$10.8M |
| 5 |
Nike
NKE
|
$10.3M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$16.8M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$10.4M |
| 3 |
Goldman Sachs
GS
|
$9.99M |
| 4 |
Zoom
ZM
|
$9.77M |
| 5 |
Procter & Gamble
PG
|
$8.4M |
Sector Composition
| 1 | Technology | 20.83% |
| 2 | Healthcare | 13.81% |
| 3 | Financials | 11.18% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Consumer Staples | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Codexis
CDXS
$218M
| $133K | ﹤0.01% |
11,933
+2,290
| +24% | +$25.5K |
|
902
Ingevity
NGVT
$2.15B
| $131K | ﹤0.01% |
3,729
+212
| +6% | +$7.45K |
|
903
Banco Macro
BMA
$3.72B
| $128K | ﹤0.01% |
7,567
| – | – |
|
|
ORTX
904
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $128K | ﹤0.01% |
1,700
+335
| +25% | +$25.2K |
|
|
ZEPP
905
Zepp Health
ZEPP
$726M
| $126K | ﹤0.01% |
2,395
+269
| +13% | +$14.2K |
|
|
CLR
906
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $125K | ﹤0.01% |
16,379
+3,515
| +27% | +$26.8K |
|
907
Novartis
NVS
$249B
| $122K | ﹤0.01% |
1,485
+339
| +30% | +$27.9K |
|
908
Tanger
SKT
$3.89B
| $122K | ﹤0.01% |
24,426
+5,746
| +31% | +$28.7K |
|
909
Sanofi
SNY
$111B
| $122K | ﹤0.01% |
2,796
+555
| +25% | +$24.2K |
|
910
YPF
YPF
$12.1B
| $121K | ﹤0.01% |
29,046
| – | – |
|
911
Iridium Communications
IRDM
$2.61B
| $120K | ﹤0.01% |
5,388
+766
| +17% | +$17.1K |
|
912
Voyager Therapeutics
VYGR
$215M
| $119K | ﹤0.01% |
13,030
+2,510
| +24% | +$22.9K |
|
913
Adeia
ADEA
$1.69B
| $117K | ﹤0.01% |
31,763
+7,295
| +30% | +$26.9K |
|
914
Galicia Financial Group
GGAL
$6.42B
| $117K | ﹤0.01% |
16,593
| – | – |
|
915
Comtech Telecommunications
CMTL
$61.4M
| $115K | ﹤0.01% |
8,666
+1,474
| +20% | +$19.6K |
|
916
HDFC Bank
HDB
$181B
| $115K | ﹤0.01% |
2,984
+520
| +21% | +$20K |
|
917
Sangamo Therapeutics
SGMO
$160M
| $115K | ﹤0.01% |
18,116
+3,437
| +23% | +$21.8K |
|
|
BLUE
918
DELISTED
bluebird bio
BLUE
| $111K | ﹤0.01% |
186
+36
| +24% | +$21.5K |
|
919
CRISPR Therapeutics
CRSP
$4.8B
| $111K | ﹤0.01% |
2,610
+597
| +30% | +$25.4K |
|
|
GMRE
920
Global Medical REIT
GMRE
$505M
| $111K | ﹤0.01% |
10,922
+2,901
| +36% | +$29.5K |
|
|
BFS
921
Saul Centers
BFS
$814M
| $110K | ﹤0.01% |
3,350
+718
| +27% | +$23.6K |
|
|
INN
922
Summit Hotel Properties
INN
$617M
| $110K | ﹤0.01% |
26,142
+4,138
| +19% | +$17.4K |
|
|
CIO
923
City Office REIT
CIO
$281M
| $109K | ﹤0.01% |
15,038
+2,765
| +23% | +$20K |
|
924
Fossil Group
FOSL
$184M
| $109K | ﹤0.01% |
32,999
+2,542
| +8% | +$8.4K |
|
|
UBA
925
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $108K | ﹤0.01% |
7,653
+1,487
| +24% | +$21K |
|